Vicki L Goodman insider trades: Mural Oncology (MURA) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Vicki reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Nov 10, 2025 | MURA | ↓ Sell | 5,036 | $2.08 | $10K | Direct | Nov 10, 2025 (0d) |
| Feb 24, 2025 | MURA | ↓ Sell | 13,186 | $3.89 | $51K | Direct | Feb 25, 2025 (1d) |
| Nov 7, 2024 | MURA | ↓ Sell | 5,069 | $3.33 | $17K | Direct | Nov 8, 2024 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Vicki L Goodman's insider trades
Vicki L Goodman is Chief Medical Officer at Mural Oncology (MURA). Since Nov 7, 2024, Vicki has reported no open-market purchases and 3 sales worth $79K on SEC Form 4. In the last 12 months: 1 sale ($10K).
Their filings also include grants and awards (4 filings), shares withheld for taxes (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MURA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.